-5%
Finerenone is used to manage chronic kidney disease (CKD) associated with type 2 diabetes (T2D). It helps to:
- Reduce the risk of worsening kidney problems.
- Lower the risk of cardiovascular events such as heart attacks.
- Decrease the need for hospitalization due to heart failure.
Finorex 20 contains the active ingredient finerenone. It belongs to a class of drugs known as non-steroidal mineralocorticoid receptor (MR) antagonists. It is indicated to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease associated with type 2 diabetes. Finorex 20 also lowered the occurrence of new-onset heart failure considerably. It acts by inhibiting the function of specific hormones (mineralocorticoids) that might cause kidney and cardiac damage.
